237 related articles for article (PubMed ID: 19684441)
21. Genome announcement: complete genome sequence of a novel Mupapillomavirus, HPV204.
Kocjan BJ; Šterbenc A; Hošnjak L; Chouhy D; Bolatti E; Giri AA; Poljak M
Acta Dermatovenerol Alp Pannonica Adriat; 2015; 24(2):21-3. PubMed ID: 26086163
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus genome variants.
Burk RD; Harari A; Chen Z
Virology; 2013 Oct; 445(1-2):232-43. PubMed ID: 23998342
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
24. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
25. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.
Frattini MG; Lim HB; Laimins LA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3062-7. PubMed ID: 8610168
[TBL] [Abstract][Full Text] [Related]
26. High-level of viral genomic diversity in cervical cancers: A Brazilian study on human papillomavirus type 16.
de Oliveira CM; Bravo IG; Santiago e Souza NC; Genta ML; Fregnani JH; Tacla M; Carvalho JP; Longatto-Filho A; Levi JE
Infect Genet Evol; 2015 Aug; 34():44-51. PubMed ID: 26160543
[TBL] [Abstract][Full Text] [Related]
27. Detection and genome characterization of two novel papillomaviruses and a novel polyomavirus in tree shrew (Tupaia belangeri chinensis) in China.
Liu P; Qiu Y; Xing C; Zhou JH; Yang WH; Wang Q; Li JY; Han X; Zhang YZ; Ge XY
Virol J; 2019 Mar; 16(1):35. PubMed ID: 30885224
[TBL] [Abstract][Full Text] [Related]
28. Phylogenetic analysis of beta-papillomaviruses as inferred from nucleotide and amino acid sequence data.
Gottschling M; Köhler A; Stockfleth E; Nindl I
Mol Phylogenet Evol; 2007 Jan; 42(1):213-22. PubMed ID: 16935527
[TBL] [Abstract][Full Text] [Related]
29. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
30. Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer.
Zhen S; Li X
Cell Physiol Biochem; 2017; 44(6):2455-2466. PubMed ID: 29268281
[TBL] [Abstract][Full Text] [Related]
31. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia.
Villa LL; Sichero L; Rahal P; Caballero O; Ferenczy A; Rohan T; Franco EL
J Gen Virol; 2000 Dec; 81(Pt 12):2959-2968. PubMed ID: 11086127
[TBL] [Abstract][Full Text] [Related]
32. Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer.
Chen Z; de Freitas LB; Burk RD
Methods Mol Biol; 2015; 1249():3-26. PubMed ID: 25348294
[TBL] [Abstract][Full Text] [Related]
33. miRNA as viral transcription tuners in HPV-mediated cervical carcinogenesis.
Shishodia G; Verma G; Das BC; Bharti AC
Front Biosci (Schol Ed); 2018 Jan; 10(1):21-47. PubMed ID: 28930517
[TBL] [Abstract][Full Text] [Related]
34. Genomic and phylogenetic characterization of ChPV2, a novel goat PV closely related to the Xi-PV1 species infecting bovines.
Willemsen A; van den Boom A; Dietz J; Bilge Dagalp S; Dogan F; Bravo IG; Ehrhardt A; Ehrke-Schulz E
Virol J; 2020 Oct; 17(1):167. PubMed ID: 33126890
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix.
Ragonnaud E; Andersson AC; Mariya S; Pedersen AG; Burk RD; Folgori A; Colloca S; Cortese R; Nicosia A; Pamungkas J; Iskandriati D; Holst PJ
J Immunother; 2017; 40(2):51-61. PubMed ID: 28166180
[TBL] [Abstract][Full Text] [Related]
36. Whole genome analysis of human papillomavirus type 16 multiple infection in cervical cancer patients.
Chansaenroj J; Theamboonlers A; Junyangdikul P; Swangvaree S; Karalak A; Poovorawan Y
Asian Pac J Cancer Prev; 2012; 13(2):599-606. PubMed ID: 22524831
[TBL] [Abstract][Full Text] [Related]
37. Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58.
Godínez JM; Heideman DA; Gheit T; Alemany L; Snijders PJ; Tommasino M; Meijer CJ; de Sanjosé S; Bosch FX; Bravo IG
Infect Genet Evol; 2013 Jan; 13():96-104. PubMed ID: 23022714
[TBL] [Abstract][Full Text] [Related]
38. The role of human papillomaviruses in human cancers.
Münger K
Front Biosci; 2002 Mar; 7():d641-9. PubMed ID: 11861215
[TBL] [Abstract][Full Text] [Related]
39. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and genotype characterization of human papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso.
Djigma FW; Ouédraogo C; Karou DS; Sagna T; Bisseye C; Zeba M; Ouermi D; Gnoula C; Pietra V; Ghilat-Avoid-Belem NW; Sanogo K; Sempore J; Pignatelli S; Ferri AM; Nikiema JB; Simpore J
Acta Trop; 2011 Mar; 117(3):202-6. PubMed ID: 21167118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]